Overview

Asthma/Steroid Withdrawal Study

Status:
Terminated
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The investigators propose to study the patterns of metabolite changes in subjects with asthma to determine if there is a predictable pattern prior to, and post, clinical exacerbation. Hypothesis: 1. Metabolite profiles will change prior to detection of a clinical exacerbation in subjects with asthma. 2. There will be a measurable temporal delay before metabolite profiles return to baseline following anti-inflammatory therapy of an exacerbation of asthma.
Phase:
Phase 4
Details
Lead Sponsor:
University of Alberta
Collaborator:
GlaxoSmithKline
Treatments:
Budesonide